You can display a site-wide message here!
Please select a theme to preview on mobile
1 2 3 4 5
Atlantic Pharmacy Logo

Get Healthy!

Results for search "Vaccines".

Show All Health News Results

Health News Results - 405

Vaccinated Americans will probably need booster shots to guard against emerging coronavirus variants in the future, a White House adviser and Pfizer's CEO said Thursday.

The United States is already planning for future booster shots, Dr. David Kessler, chief science officer for the pandemic response, said during a House subcommittee hearing on the country's vaccination efforts.

<...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • April 16, 2021
  • |
  • Full Page

While U.S. federal government experts probe potential risks of the Johnson & Johnson vaccine, what do you need to know if you have had the one-dose COVID shot or hope to get it?

Experts at the American Heart Association (AHA) describe what to look out for.

The U.S. Centers for Disease Control and Prevention and the U.S. Food & Drug Administration paused administration of the J&J (J...

Young adults, take note: A new study finds that even if you have suffered a bout of COVID-19, it is not a guarantee against a second infection.

Researchers said the results show that even those young people who've been struck by the new coronavirus still need to be vaccinated against it.

The study was conducted between May and November 2020 and included more than 2,300 healthy U.S. ...

THURSDAY, April 15, 2021 (HealthDay News) -- Dermatologists liken skin to a window that can reveal what is going on inside the body, and a rash that sometimes follows a COVID-19 vaccine is one example.

When you get the shot, your immune system activates, preparing to recognize and fight off the virus in the future. This response and the inflammation that goes with it ca...

Many American teens and young adults are now embracing the chance to get COVID-19 vaccines, a new survey finds.

But youth-focused messaging will still be needed to convince a minority of those aged 14 to 24 that they should be vaccinated, the University of Michigan researchers said. Still, the good news is that more young people are ready to get their shots than said they were ready to do...

The fate of Johnson & Johnson's coronavirus vaccine hung in the balance on Thursday after a government advisory committee said it needed more time and evidence to determine whether unusual, but severe, blood clots seen in a handful of people were caused by the vaccine.

So far, only six clotting cases have been officially reported out of more than 7 million shots given of the one-dose...

The Biden Administration sought to reassure Americans on Tuesday that the pausing of Johnson & Johnson's coronavirus vaccine is science at work, and not evidence that COVID-19 vaccines are unsafe.

The pause was first issued Tuesday morning following reports that rare but serious blood clots had developed in six women after they took J&J's vaccine. The Advisory Committee on Immunizati...

Extremely rare but life-threatening blood clots linked to the Johnson & Johnson COVID-19 vaccine appear similar to those caused by the AstraZeneca vaccine approved for use in Europe and Canada, U.S. health officials said Tuesday.

Federal officials called for a "pause" in use of the one-dose J&J vaccine while they review data linked to six women between 18 and 48 years of age who developed...

If you've got questions about COVID-19 vaccines, you're not the only one. Even as many people rush to get their shots, surveys show others just aren't sure about them.

Dr. Won Lee, medical director of Boston Medical Center's Home Care Program, understands. "There's so much misinformation out there," she said. "And it's hard for anyone to know what to believe."

Lee is part of a medic...

After six people who received the Johnson & Johnson one-dose COVID-19 vaccine developed a type of rare and severe blood clot, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention on Tuesday each said they will seek a "pause" in use of the shots as they review the data.

The six cases involved what's known as a cerebral venous sinus thrombosis (CVST), a ...

Two new studies out of Britain find that although the now-dominant "U.K. variant" of the new coronavirus does spread more quickly, it does not appear to lead to more severe disease in those made ill.

The findings should help allay fears that more patients will die after infection with the variant, officially labeled B.1.1.7.

Scientists published the findings online April 12 in two<...

People living with someone who has COVID-19 appear to get powerful protection against infection when they are given Regeneron's antibody cocktail, a new study shows.

The findings suggest that beyond preventing the worst outcomes for coronavirus infection when given early enough, the cocktail could also prevent people from getting sick in the first place, the company said Monday.

<...

Once you've landed that coveted coronavirus vaccine appointment, you'll likely have to fill out a form on your medical history and whether you're allergic to any of the vaccine's ingredients. But there could be another question waiting for you: Have you ever had dermal filler injections?

That's because -- in rare cases -- people who've had the face-plumping injections can develop a mild, ...

People with cancers of the blood, bone marrow or lymph nodes are at an increased risk of not making protective coronavirus antibodies after COVID-19 vaccination, a new study warns.

The risk is particularly high for those with chronic lymphocytic leukemia (CLL). The researchers urged these patients and those who interact with them to get vaccinated but to keep wearing masks and practicing...

Older adults in long-term care develop detectible antibodies after COVID-19 vaccination, which may mean it's safe to reopen these facilities, according to a new study.

But because it's unclear how long the antibodies last, researchers from University of Pittsburgh Medical Center (UPMC) say there's still a need to monitor symptoms and controls on reopening.

"COVID-19 hit long-term ca...

Doctors might have figured out why AstraZeneca's COVID-19 vaccine may cause life-threatening blood clots in very rare cases.

The discovery, made in a pair of reports published online Friday in the New England Journal of Medicine, could be key to the global rollout of the AstraZeneca vaccine, helping develop effective treatments for the side effect and providing clue...

In a setback to a national vaccination campaign that was finally gaining ground, the federal government said Thursday that Johnson & Johnson will allocate 86 percent fewer doses of its coronavirus vaccine across the United States next week.

The company delivered the first batch of its single-dose vaccine at the beginning of March, sending 2.8 million doses across the country before d...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • April 9, 2021
  • |
  • Full Page

A new clinical trial will investigate whether people who are highly allergic or have what's known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines.

"The public understandably has been concerned about reports of rare, severe allergic reactions to the Moderna and Pfizer-BioNTech COVID-19 vaccines," said Dr. Anthony Fauci, d...

Two COVID-19 vaccines appear to work well against a rapidly spreading coronavirus variant that arose in California, but less effective against a variant that first emerged in South Africa, researchers report.

"The good news is the California variant does not appear to be a problem for our current vaccines," said study author David Montefiori, director of the Laboratory for AIDS Vaccine Re...

Two people in the Johnson & Johnson COVID-19 vaccine trial developed Guillain-Barré syndrome, but it's highly doubtful the vaccine is to blame, according to a just-published case study.

Although both people were in the same trial, one was given the vaccine and the other was given a placebo of saline solution.

"That strengthens the possibility that the case in our report may have be...

In findings that bode well for the full reopening of schools across America, a new government survey shows that nearly 80 percent of school employees and child care workers have received at least one dose of a coronavirus vaccine.

Released by the U.S. Centers for Disease Control and Prevention on Tuesday, the latest figures came as the Biden administration pushes to reopen schools by...

There's good news for the millions of Americans who've already received a dose or two of Moderna's COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months.

The new study tracked 33 participants in the trials that led to the vaccine's approval. Six months after having received their second vaccine dose, "antibody activity remained high in al...

The U.S. government won't require vaccine passports for travel and businesses, the nation's top infectious diseases expert said Monday.

"I doubt that the federal government will be the main mover of a vaccine passport concept," Dr. Anthony Fauci said during a Politico Dispatch podcast.

The federal government "may be involved in making sure things are done fairly and eq...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • April 6, 2021
  • |
  • Full Page

The sooner a pregnant woman gets a COVID-19 vaccine, the more likely she is to transfer protective antibodies to her baby, a new, small study suggests.

"This just gives extra fuel for people who are on the fence or just think, 'Maybe I'll wait until after I deliver,'" said study co-author Dr. Emily Miller. She's an assistant professor of obstetrics and gynecology and a maternal fetal medi...

A new U.S. study offers more evidence that a single dose of a two-dose COVID-19 vaccine may provide enough protection to people who've previously been infected with the coronavirus.

"Our findings extend those from smaller studies reported elsewhere and support a potential strategy of providing a single dose of vaccine to persons with a confirmed prior history of coronavirus infection, al...

Despite the recent contamination of 15 million doses of Johnson & Johnson's coronavirus vaccine at a Baltimore plant, the Biden administration on Sunday reassured Americans that there will still be enough doses to vaccinate every American adult by the end of May.

Johnson & Johnson will take over responsibility for manufacturing at the plant, U.S. health officials announced late Satu...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • April 5, 2021
  • |
  • Full Page

Just because you've had your COVID-19 vaccination doesn't mean you can stop taking steps to protect yourself and others, experts say.

So far, only about 16% of Americans have been fully vaccinated, and on March 24, the U.S. Centers for Disease Control and Prevention reported a 6.7% increase in the seven-day average number of daily cases, compared to the prior week.

About 60,000 peo...

Many Americans are fine with donating at least some COVID-19 vaccines to less wealthy nations, but that support varies between different groups, a new poll finds.

Recent estimates show that wealthy countries -- which have just one-fifth of the world's adult population -- have bought more than half of the world's total vaccine doses, leaving less for low- and middle-income countries.

Kids will be kids, and that's exactly why Holly McDade plans to get her three young children the COVID-19 vaccine as soon as it becomes available to them.

"Little kids can't help but touch their mouths and their noses and touch other things," said McDade, 32, of Strasburg, Va. "They just don't think about it. It's not where their brains are at yet."

McDade isn't concerned so much ab...

In a push to overcome vaccine hesitancy, the Biden administration on Thursday launched a public outreach effort that will focus on communities that have been hit hardest by the pandemic.

Called the "We Can Do This" campaign, the project features television and social media ads and creates a "community corps" of public health, athletic, faith and other groups to spread the word about the s...

The faster-spreading COVID-19 variant first detected in the United Kingdom is on its way to becoming the dominant form of the virus in the United States.

A new study found that the B.1.1.7 variant is being detected in an increasing proportion of SARS-CoV-2 samples and is 40% to 50% more transmissible than versions of the virus that were previously dominant.

Together with previous re...

More than one-quarter of U.S. parents don't plan to vaccinate their kids for COVID-19, and roughly as many oppose school-required coronavirus shots, a new study finds.

This opposition was more common among moms than dads, and was especially common among white mothers who identified as Republican/Republican-leaning, the researchers said.

"Women tend to serve as family health managers...

In a finding that illustrates the heavy toll the pandemic has taken on America, a new government report confirms that COVID-19 became the third leading cause of death in 2020.

Researchers from the U.S. Centers for Disease Control and Prevention say that more than 547,000 lives have been lost to COVID-19 since the pandemic began last spring. Only the two long-term biggest killers, hea...

It's the question everyone wants answered because reopening the world depends on it: Can coronavirus vaccines stop transmission of the virus?

Now, 21 universities across the United States are teaming up to find out.

The project, called Prevent COVID U, was started by the COVID-19 Prevention Network housed at the Fred Hutchinson Cancer Research Center in Seattle.

The study inc...

Pfizer Inc. announced Wednesday that its coronavirus vaccine is safe and remarkably effective in children as young as 12.

In a news release issued by Pfizer and its vaccine development partner, BioNTech, company executives said data from a trial of the vaccine in nearly 2,300 people between the ages of 12 and 15 will be submitted to the U.S. Food and Drug Administration in the coming...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • March 31, 2021
  • |
  • Full Page

As new coronavirus cases begin to rise again across America, President Joe Biden on Monday called on governors to bring back state mask mandates.

Just hours earlier, Dr. Rochelle Walensky, head of the U.S. Centers for Disease Control and Prevention, delivered an emotional plea to Americans to keep following social distancing measures to stem the spread of COVID-19.

The former H...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • March 30, 2021
  • |
  • Full Page

The two-dose mRNA vaccines from Pfizer and Moderna have proven to be potent weapons against COVID-19 infection among health care workers, first responders and essential workers in the real world, a new U.S. government study shows.

After following nearly 4,000 volunteers in six states over a 13-week period, researchers from the U.S. Centers for Disease Control and Prevention found the risk...

The Biden administration and private companies are working to develop a standard for a "vaccine passport" that could be used as the country tries to reopen in the coming months.

The effort has gained steam following President Biden's pledge that the nation will begin to return to normal this summer and with a growing number of companies saying they will require proof of vaccination b...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • March 29, 2021
  • |
  • Full Page

Fifteen years of widespread vaccination of U.S. children with the human papillomavirus (HPV) vaccine is reaping big rewards: A more than 80% drop in new infections has been seen in women and girls under the age of 25.

That could mean an equally big drop to come in a host of dangerous conditions that are linked to HPV infection, including cancers of the cervix, anogenital area and mouth/th...

States are scrambling to vaccinate as many people as they can while the rate of new U.S. coronavirus infections stays steady, but still high, for a third week.

At more than 55,000 new COVID-19 cases a day, public health experts believe that is a level that could rapidly become yet another surge, The New York Times reported.

A sense of urgency is being felt keenly by st...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • March 26, 2021
  • |
  • Full Page

In some good news to emerge from the coronavirus pandemic, new research shows that pregnant women and new breastfeeding moms have a strong immune response to COVID-19 vaccines and can transfer that immunity to their infants.

The study included 131 women of reproductive age (84 pregnant, 31 lactating and 16 not pregnant) who received one of two mRNA vaccines: Pfizer or Moderna.

Vacc...

Following a sharp rebuke from an independent oversight board over potentially misleading information on the effectiveness of its coronavirus vaccine, AstraZeneca released new data late Wednesday that showed the vaccine is slightly less effective than the company claimed on Monday.

The pharmaceutical giant stressed that its vaccine is still very powerful at preventing infection with C...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • March 25, 2021
  • |
  • Full Page

It's very rare, but it is possible to catch COVID-19 even if you've been vaccinated, a new study finds.

Looking at vaccinated health care workers at two University of California campuses, researchers found a tiny number tested positive for the virus. This finding highlights the need to keep wearing a mask and to keep social distancing, the researchers said.

"Because of the compulso...

Health care workers were just as uneasy as everyone else when COVID-19 vaccines were about to be approved in the United States, with large numbers hesitant to take the shot in early December, a new study reveals.

But that hesitancy dwindled over the next few weeks, as health system employees learned more about the safety and efficacy data gathered during clinical trials of the vaccines, r...

U.S. health officials called the results of AstraZeneca's coronavirus vaccine trial into question early Tuesday, saying the company may have used outdated data that could have changed its conclusion about the efficacy of the vaccine.

On Monday morning, AstraZeneca had announced that its vaccine was 79 percent effective in protecting against COVID-19 infection in the large U.S. clinic...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • March 23, 2021
  • |
  • Full Page

AstraZeneca's coronavirus vaccine was 79 percent effective in protecting against COVID-19 infection in a large U.S. clinical trial, the company announced Monday.

The findings may help restore confidence in the vaccine that was lost recently after more than a dozen countries, mostly in Europe, suspended use of the shot following reports of rare blood clots. Most of those countries ret...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • March 22, 2021
  • |
  • Full Page

The U.S. COVID-19 vaccination program is proceeding apace, with more than one-fifth of adult Americans having received at least one dose and eligibility opening up for everyone by May 1, under orders from President Joe Biden.

That means the fully vaccinated now have one pressing question: What can I do now that I haven't been able to do before?

In a new

  • Dennis Thompson HealthDay Reporter
  • |
  • March 19, 2021
  • |
  • Full Page
  • President Joe Biden said Thursday that his administration's promise of 100 million vaccinations in the first 100 days of his administration will be met Friday, more than 40 days ahead of schedule.

    "I'm proud to announce that tomorrow, 58 days into our administration, we will have met our goal," Biden said during a speech on the state of the country's vaccination campaign. He added th...

    • Ernie Mundell and Robin Foster HealthDay Reporters
    • |
    • March 19, 2021
    • |
    • Full Page

    Fewer than 1 in 10 people in Wuhan carried COVID-19 antibodies in their bloodstream four months after the coronavirus outbreak in the Chinese city that served as a harbinger of a global pandemic, a new study shows.

    Further, only about 40% of those people tested positive for the sort of neutralizing antibodies needed to stave off a future infection, according to the report, published March...

    Don't believe everything you hear: A sizable minority of Americans are still hesitant about getting the new COVID-19 vaccine, but their fears are mostly not warranted, a leading vaccine expert says.

    "Not only has it been shown to be safe in tens of thousands of people before approval, it's been shown to be safe in tens of millions of people post-approval," Dr. Paul Offit, director of the ...

    Show All Health News Results